Jaguar Health Inc.

(JAGX) Trade

By |

Profile

Jaguar Health Inc is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products. The company's wholly-owned subsidiary, Napo Pharmaceuticals, Inc focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the marketplace from plants used traditionally in rainforest areas. It operates into two business segments namely Humal health and animal health. Its Mytesi (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Contact Information

Website: www.jaguar.health
Email: dmerrick@endeavourmining.com
Main Phone: +1 415 371-8300
Address: 201 Mission Street
Address 2: Suite 2375
State: CA
City / Town: San Francisco
Country: USA
Postal Code: 94105

Issuer Information

Exchange: NSC
CEO: Lisa A Conte
Employees: 40
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Jaguar Health Inc is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products. The company's wholly-owned subsidiary, Napo Pharmaceuticals, Inc focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the marketplace from plants used traditionally in rainforest areas. It operates into two business segments namely Humal health and animal health. Its Mytesi (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Contact Information

Website: www.jaguar.health
Email: dmerrick@endeavourmining.com
Main Phone: +1 415 371-8300
Address: 201 Mission Street
Address 2: Suite 2375
State: CA
City / Town: San Francisco
Country: USA
Postal Code: 94105

Issuer Information

Exchange: NSC
CEO: Lisa A Conte
Employees: 40
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 5.21 $ -0.41 (-7.30%)
Last Price 5.21 Change $ -0.41 Change % -7.30 Tick N/A
Bid 5.17 Bid Size 400.00 Ask 5.25 Ask Size 2,100.00
Open 5.60 High 5.70 Low 5.15 Prev Close 5.62
Last Trade Volume 529,860 52 Wk Hi 175.00 52 Wk Low 5.52
Market Cap 8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 1,528,498.00 EPS (TTM) -125.30 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 1
Number of Buys 0 1
Number of Sells 0 0
Net Activity 0 100000
Last 10 Buys Shares
James J. Bochnowski 1,000
James J. Bochnowski 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.25 1.25 1.25 1.25
Low Target Price Estimate 1.25 1.25 1.25 1.25
Mean Target Price Estimate 1.25 1.25 1.25 1.25
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 12/19/17 12/19/17 12/19/17 12/19/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1